Mixed tocopherols inhibit platelet aggregation in humans: Potential mechanisms

American Journal of Clinical Nutrition

Volumn 77, Issue 3, 2003, Pages 700-706

  Liu, Meilin ^a   Wallmon, Agneta ^a   Olsson Mortlock, Caroline ^a   Wallin, Rolf ^a   Saldeen, Tom ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Endothelial constitutive nitric oxide synthase; Mixed tocopherols; Nitric oxide; Platelet aggregation; Platelets; Protein kinase C; Superoxide dismutase; Tocopherols; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; CARDI E; GAMMA TOCOPHEROL; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENCY; ENZYME ACTIVATION; FEMALE; HUMAN; IMMUNOPRECIPITATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; WESTERN BLOTTING;

EID: 0037369662     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.3.700     Document Type: Article

References (43)

1. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
2. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
3. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334: 1156-62.
4. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996;64:190-6.
5. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:154-60.
6. GISSI. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-55.
7. Wolf G. γ-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr Rev 1997;55:376-8.
8. Ohrvall M, Sundlof G, Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 1996;239:111-7.
9. Conti CR, Mehta JL. Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism. Circulation 1987;75:V84-95.
10. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
11. Handin RI. Platelets and coronary artery disease. N Engl J Med 1996; 334:1126-7.
12. Saldeen T, Li D, Mehta JL. Differential effects of alpha- and gammatocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol 1999;34:1208-15.
13. Ohrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med 1993;234:53-60.
14. American Oil Chemist's Society. Determination of tocopherols and tocotrienols in vegetable oils and fats by HPLC. Sampling and analysis of commercial fats and oils. Champaign, IL: American Oil Chemist's Society, 1990. (Official method Ce 8-89, revised.)
15. Schmidt HHW. Determination of nitric oxide via measurement of nitrite and nitrate in culture media. Biochemica 1995;2:22-3.
16. Li D, Tomson K, Yang B, Mehta P. Croker BP, Mehta JL. Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxiareoxygenation and angiotensin II: role of AT1 receptor activation. Cardiovasc Res 1999;41:109-15.
17. Li D, Saldeen T, Romeo F, Mehta JL. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E. J Cardiovasc Pharmacol Ther 2001;6:155-61.
18. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids.: Washington, DC: National Academy Press, 2000.
19. Steiner M, Anastasi J, Vitamin E. An inhibitor of the platelet release reaction, J Clin Invest 1976;57:732-7.
20. Srivastava KC. Vitamin E exerts antiaggregatory effects without inhibiting the enzymes of the arachidonic acid cascade in platelets. Prostaglandins Leukot Med 1986;21:177-85.
21. Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996;94:2434-40.
22. Mabile L, Bruckdorfer KR, Rice-Evans C. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atherosclerosis 1999; 147:177-85.
23. Stampfer MJ, Jakubowski JA, Faigel D, Vaillancourt R, Deykin D. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels. Am J Clin Nutr 1988;47:700-6.
24. Kockmann V, Vericel E, Croset M, Lagarde M. Vitamin E fails to alter the aggregation and the oxygenated metabolism of arachidonic acid in normal human platelets. Prostaglandins 1988;36: 607-20.
25. Freedman JE, Ting B, Hankin B, Loscalzo J, Keaney JF Jr, Vita JA. Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation 1998;98:1481-6.
26. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997;100:350-6.
27. Freedman JE, Li L, Sauter R, Keaney JJ. α-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release. FASEB J 2000;14:2377-9.
28. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 1993;18:195-9.
29. Rubbo H, Radi R, Trujillo M, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994;269:26066-75.
30. Freedman JE, Sauter R, Battinelli EM, et al. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOS III gene. Circ Res 1999;84:1416-21.
31. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A 1997;94: 3217-22.
32. Li D, Saldeen T, Romeo F, Mehta JL. Relative effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J Cardiovasc Pharmacol Ther 1999;4:219-26.
33. Buczynski A, Wachowicz B, Kedziora-Kornatowska K, Tkaczewski W, Kedziora J. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 1993;100: 223-8.
34. Okuma M, Steiner M, Baldini G. Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody. J Lab Clin Med 1971;77:728-42.
35. Muller M, Sorrell TC. Oxidative stress and the mobilisation of arachidonic acid in stimulated human platelets: role of hydroxyl radical. Prostaglandins 1997;54:493-509.
36. Handin RI, Karabin R, Boxer GJ. Enhancement of platelet function by superoxide anion. J Clin Invest 1977;59:959-65.
37. Freedman J, Keaney J. NO and superoxide in human platelets. In: Packer L, ed. Nitric oxide, part C. Biological and antioxidant activities. San Diego: Academic Press, 1999:61-7.
38. Mehta J, Li D, Mehta JL. Vitamins C and E prolong time to arterial thrombosis in rats. J Nutr 1999;129:109-12.
39. Salonen JT, Salonen R, Seppanen K, et al. Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am J Clin Nutr 1991;53:1222-9.
40. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A. α-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 1998; 334:243-9.
41. Freedman JE, Keaney JF Jr. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001;131: 374S-7S.
42. Ohmori T, Yatomi Y, Asazuma N, Satoh K, Ozaki Y. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2. Biochem J 2000;347:561-9.
43. Packham MA, Livne AA, Ruben DH, Rand ML. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid. Biochem J 1993;290: 849-56.